n advance of an upcoming meeting on regional trade, the U.S. trade representative urged the Colombian government to overhaul various practices for making medicines available, a topic that has increasingly angered the U.S. pharmaceutical industry.

In a Feb. 14 letter, Robert Lighthizer wrote to the Colombian trade minister that “key stakeholders remain dissatisfied” with government policies. The letter was sent as a meeting nears this month, according to sources, to discuss membership in the Organization for Economic Cooperation and Development, an intergovernmental group of three dozen countries that was created to stimulate economic progress and world trade.

This is a STAT Plus article and you can unlock it by subscribing to STAT Plus today. It's easy! Your first 30 days are free and if you don't enjoy your subscription you can cancel any time.
Already a subscriber? Log in here.

Leave a Comment

Please enter your name.
Please enter a comment.

Recommended Stories

Pharmaceutical production
Drug Pricing

Sign up for our Morning Rounds newsletter

Your daily dose of what’s new in health and medicine.